Pressure sensing extracorporeal circulation device
US-2017258980-A1 · Sep 14, 2017 · US
Smart artificial lung and perfusion systems
US12233189B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12233189-B2 |
| Application number | US-201917054909-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2019 |
| Priority date | Jun 20, 2018 |
| Publication date | Feb 25, 2025 |
| Grant date | Feb 25, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An artificial lung system for a patient having a membrane lung system having an gas inlet, a blood inlet, a blood outlet, and an exhaust; a gas system operably coupled to the gas inlet of the membrane lung system; a gas phase CO2 sensor disposed downstream of the exhaust of the membrane lung system and monitoring an exhaust gas CO2 (EGCO2) level and/or an blood oxygen saturation sensor disposed upstream of the blood inlet of the membrane lung system and monitoring a blood oxygen saturation level; and a feedback controller receiving the CO2 signal and/or blood oxygen saturation signal and outputting a control signal to control gas flow and/or blood flow.
First claim
Opening claim text (preview).
What is claimed is: 1. An artificial lung system for a patient, the system comprising: a membrane lung system having an gas inlet, a blood inlet, a blood outlet, and an exhaust; a gas system operably coupled to the gas inlet of the membrane lung system for introducing gas to the membrane lung system; a gas phase CO2 sensor disposed downstream of the exhaust of the membrane lung system and monitoring an exhaust gas CO2 (EGCO2) level, the gas phase CO2 sensor outputting a CO2 signal in response to a detected EGCO2 level; and a feedback controller receiving the CO2 signal and outputting an gas system control signal to the gas system responsive thereto such that if EGCO2 content increases relative to a target CO2 level, the feedback controller increases sweep flow of the gas system to remove more CO2 from the blood flowing through the blood inlet to the blood outlet, if EGCO2 content decreases relative to the target CO2 level, the feedback controller automatically decreases sweep flow of the gas system to reduce CO2 removal. 2. The artificial lung system according to claim 1 , further comprising: a water trap being disposed between the exhaust of the membrane lung system and the gas phase CO2 sensor. 3. The artificial lung system according to claim 1 , further comprising: a blood oximeter disposed upstream from the blood inlet of the membrane lung system. 4. The artificial lung system according to claim 1 wherein the gas system comprises a gas cylinder. 5. The artificial lung system according to claim 1 wherein the gas system comprises an oxygen concentrator. 6. The artificial lung system according to claim 1 wherein the gas system comprises a gas flow controller. 7. The artificial lung system according to claim 1 , further comprising: a blood oxygen saturation sensor disposed upstream of the blood inlet of the membrane lung system and monitoring a blood oxygen saturation level, the blood oxygen saturation sensor outputting a blood oxygen saturation signal in response to a detected blood oxygen saturation level, wherein the feedback controller receiving the blood oxygen saturation signal and outputting a blood flow control signal to control the flow of blood through the membrane lung system. 8. The artificial lung system according to claim 1 wherein the feedback controller comprises a proportional-integral-derivative (PIO) feedback controller.
Assignees
Inventors
Classifications
partial oxygen pressure (P-O2) · CPC title
partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2) · CPC title
Measuring or controlling the flow rate · CPC title
Measuring · CPC title
with a vapour trap · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12233189B2 cover?
- An artificial lung system for a patient having a membrane lung system having an gas inlet, a blood inlet, a blood outlet, and an exhaust; a gas system operably coupled to the gas inlet of the membrane lung system; a gas phase CO2 sensor disposed downstream of the exhaust of the membrane lung system and monitoring an exhaust gas CO2 (EGCO2) level and/or an blood oxygen saturation sensor disposed…
- Who is the assignee on this patent?
- Univ Michigan Regents, Us Gov Veterans Affairs
- What technology area does this patent fall under?
- Primary CPC classification A61M1/1698. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).